18 February 2018
News and Views
Links and Services
December's issue of Clinical Gastroenterology & Hepatology pooled the evidence on the safety of long-term treatment with certolizumab pegol in patients with Crohn's disease.
Treatments for Crohn’s disease have been linked to serious infections, malignancies, an
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors